Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Lung Neoplasms × sintilimab × Clear all

Phase

Status

Unknown 5 Recruiting 2 Completed 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 9 Carcinoma, Hepatocellular 7 Carcinoma, Non-Small-Cell Lung 6 Nasopharyngeal Carcinoma 3 Recurrence 2 Rectal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Uterine Cervical Neoplasms 1 Turcot syndrome 1 Thyroid Neoplasms 1 Squamous Non-Small Cell Lung Cancer SqNSCLC 1 Resectable Non-small Cell Lung Cancer 1 Rare Tumour 1 Pancreatic Neoplasms 1 Pancreatic Cancer Resectable 1 Pancreatic Cancer Metastatic 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1 Hodgkin Disease 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colorectal Cancer Metastatic 1 Colorectal Cancer Liver Metastasis 1 Colonic Neoplasms 1

Interventions

Drug Therapy 9 Specimen Handling 8 Magnetic Resonance Spectroscopy 7 osimertinib 6 Carboplatin 6 atezolizumab 4 Pemetrexed 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Injections 3 durvalumab 2 cemiplimab 2 anlotinib 2 Surgical Procedures, Operative 2 Standard of Care 2 Radiosurgery 2 Magnetic Resonance Imaging 2 Immunotherapy 2 Etoposide 2 Educational Status 2 Cisplatin 2 Blood Specimen Collection 2 Biopsy 2 Bevacizumab 2 Anesthesia 2 Acupuncture Therapy 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 tremelimumab 1 tislelizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06688656 2024-11-14

Peri-E

Shanghai Chest Hospital

Phase 2 Not yet recruiting

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡